中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [33]
昆明植物研究所 [8]
昆明动物研究所 [6]
南海海洋研究所 [2]
金属研究所 [2]
大连化学物理研究所 [2]
更多
采集方式
OAI收割 [60]
iSwitch采集 [1]
_filter
_filter
_filter
筛选
浏览/检索结果:
共61条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Design, synthesis and structure-activity relationship of 1,8-naphthalimide derivatives as highly potent hCYP1B1 inhibitors
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 卷号: 107, 页码: 8
作者:
Wei, Yueyue
;
Xiong, Yuan
;
Liao, Qingyi
;
Yang, Ya
;
Tian, Tian
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2024/07/12
8-naphthalimide
Structure -activity relationships (SAR)
Paclitaxel (PTX) resistance
Molecular docking
Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 267, 页码: 13
作者:
Guan, Dezhong
;
Fang, Lincheng
;
Feng, Mingshun
;
Guo, Shi
;
Xie, Lingfeng
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2024/05/07
ENPP1 inhibitors
cGAS-STING pathway
2 ', 3 '-cGAMP
Tumor immunotherapy
Discovery of GPX4 inhibitors through FP-based high-throughput screening
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 265, 页码: 14
作者:
Cao, Yu
;
Wu, Bin
;
Xu, Ying
;
Wang, Mingchen
;
Wu, Xinyu
  |  
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2024/02/27
GPX4 inhibitor
HTS assay
Ferroptosis
Fluorescence polarization
Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors
期刊论文
OAI收割
CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 卷号: 378, 页码: 11
作者:
Yang, Yun
  |  
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2023/10/17
Human carboxylesterase 2 (hCES2A)
Berberine analogues
Structure -activity relationships (SAR)
Inhibition kinetics
Selectivity
Synthesis and Biochemical Evaluation of 8H-Indeno[1,2-d]thiazole Derivatives as Novel SARS-CoV-2 3CL Protease Inhibitors
期刊论文
OAI收割
MOLECULES, 2022, 卷号: 27, 期号: 10, 页码: 11
作者:
Wu, Jing
;
Feng, Bo
;
Gao, Li-Xin
;
Zhang, Chun
;
Li, Jia
  |  
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2022/08/16
COVID-19
M-pro inhibitors
drug design and synthesis
structure-activity relationships (SAR)
Synthesis and biological evaluation of 2,5-diaryl-1,3,4-oxadiazole derivatives as novel Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) inhibitors
期刊论文
OAI收割
BIOORGANIC CHEMISTRY, 2021, 卷号: 116, 页码: 13
作者:
Meng, Xiang-Dong
;
Gao, Li-Xin
;
Wang, Zhi-Jia
;
Feng, Bo
;
Zhang, Chun
  |  
收藏
  |  
浏览/下载:78/0
  |  
提交时间:2021/12/01
2,5-diphenyl-1,3,4-oxadiazole derivatives
SHP2
Inhibitors
Structure-activity relationships (SAR)
分子模拟应用于岩藻糖化糖胺聚糖 3D 结构确定及其与内源 性因子 X 酶的相互作用模式考察
学位论文
OAI收割
2021
作者:
陈鼎元
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2023/11/02
Exploration of the SAR Connection between Morphinan- and Arylacetamide-Based kappa Opioid Receptor (kappa OR) Agonists Using the Strategy of Bridging
期刊论文
OAI收割
ACS CHEMICAL NEUROSCIENCE, 2021, 卷号: 12, 期号: 6, 页码: 1018-1030
作者:
Liu, Xiao
;
Jiang, Shuang
;
Kong, Linghui
;
Ye, Rongrong
;
Xiao, Li
  |  
收藏
  |  
浏览/下载:100/0
  |  
提交时间:2021/05/24
Morphinans
arylacetamidyl substituent
kappa opioid receptor modulators
structure-activity relationships
Synthesis and Structure-Activity Relationships of Ring-Opened Bengamide Analogues against Methicillin-Resistant Staphylococcus aureus(dagger)
期刊论文
OAI收割
CHINESE JOURNAL OF CHEMISTRY, 2021, 卷号: 39, 期号: 3, 页码: 671-676
作者:
Yu, Chen-Xi
;
Wei, Bing-Yan
;
Kong, Xue-Qing
;
Yang, Cai-Guang
;
Nan, Fa-Jun
  |  
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2021/05/24
Bengamides
Staphylococcus aureus
Antibiotics
Structure‐
activity relationships
Pharmacokinetic
Chemical Synthesis of the Nucleoside Antibiotic Capuramycin
期刊论文
OAI收割
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2021, 卷号: 2021, 期号: 26, 页码: 3681-3689
作者:
Xiao,Guozhi
;
He,Haiqing
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2022/04/02
Capuramycin
Chemical synthesis
Glycosyl ortho-(1-phenylvinyl)benzoates
One-pot glycosylation
Tuberculosis
DRUG-RESISTANT TUBERCULOSIS
GLUTAMIC-ACID-DERIVATIVES
MULTIDRUG-RESISTANT
PROTECTING GROUPS
IN-VITRO
GLYCOSYLATION
INHIBITORS
ALCOHOLS
ANALOGS
OXIDATION